Organisation paid for research Program year 2025 Source: CMS Open Payments

Trihealth Inc

Neither a doctor nor a teaching hospital

Research payments

$1,184,549

271 payments

Through program year 2025, Trihealth Inc is reported as receiving $1,184,549 in research payments, across 271 payments.

By program year

6 rows

Year	Kind	Amount	Payments
2025	Research	$625,129	127
2024	Research	$252,012	50
2023	Research	$145,634	48
2022	Research	$81,963	27
2021	Research	$74,426	18
2020	Research	$5,385	1

Breakdown

Who paid Research payments · program years 2020–2025

Boston Scientific Corporation $614,335 135 payments
Pfizer Inc. $185,285 25 payments
Biosense Webster, Inc. $75,937 16 payments
Takeda Pharmaceuticals U.S.A., Inc. $66,679 6 payments
Abbott Laboratories $63,265 24 payments
Siemens Medical Solutions USA, Inc. $35,965 3 payments
GlaxoSmithKline, LLC. $35,339 10 payments
Atricure, Inc. $21,952 13 payments
Bayer HealthCare Pharmaceuticals Inc. $20,300 5 payments
Urovant Sciences Inc $19,697 11 payments

Studies the money was for Research payments · program years 2020–2025

Simplaafy $239,951 21 payments
A Phase 3 Openlabel Study of Elranatamab Monotherapy Versus Elotuzumab Pomalidomide Dexamethasone Epd Or Pomalidomide Bortezomib Dexamethasone PVD Or Carfilzomib Dexamethasone KD in Participants With Relapsedrefractory Multiple Myeloma Who Received Prior Anticd38 Directed Therapy $185,285 25 payments
Advantage Af $103,765 31 payments
Avant Guard $82,419 17 payments
A Pivotal Investigational Device Exemption Study on Laminar Left Atrial Appendage Elimination $75,937 16 payments
A Phase 1B/2 Open-Label, Multicenter Study to Evaluate the Safety and Efficacy of Tak-981 in Combination With Monoclonal Antibodies in Adult Patients With Relapsed And/Or Refractory Multiple Myeloma $66,679 6 payments
Lux DX Perform $40,154 17 payments
Newton Af $38,591 8 payments
A Phase 3, Open-Label, Randomized Study of Perioperative Dostarlimab M $35,339 10 payments
POLARx PAS $33,748 8 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.